Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
Takeaways from this week in optometry: October 27 - October 31 | Optometry Times - Clinical News
Published on November 4, 2025
Catch up on the top stories in optometry during the week of October 27-October 31.
Continue reading on website
Other news
Kalaris Therapeutics Appoints Matthew Gall as Chief Financial Officer
November 4, 2025
PALO ALTO, Calif.—Kalaris Therapeutics, a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for common retinal diseases, announced the expansion of its leadership team with the appointment of Matthew Gall, MBA, as its new chief financial officer (CFO). The appointment comes as Kalaris enrolls patients in its Phase 1b/2 study for treatment-naïve neovascul
Retinal diseases in the cross hairs of optometrists at Academy 2025 | Optometry Times - Clinical News
November 4, 2025